Want a feel-good side gig that requires no work, no skill and no experience? Consider plasma donation through CSL Plasma. It’s a lot like giving blood, but you get paid — sometimes generously. CSL ...
With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a rebound—fueled by a surge in post-pandemic collections and an $11.7 ...
Add Yahoo as a preferred source to see more of our stories on Google. Feb. 27—Two Southern Oregon residents are suing CSL Plasma for millions of dollars, saying that their blood plasma donations in ...
Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by pledging a capital investment of about $1.5 billion for U.S.-based ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is also closing two ...
CSL trades at a discount despite owning a dominant, hard-to-replicate global plasma-derived therapies infrastructure. Transformation Program targets $500–$550M in annual pre-tax cost reductions by ...
CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated as plasma sourcing is a key constraint in ...
Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee. CSL will expand its current footprint ...
SYDNEY, Feb 16 (Reuters) - Australian biopharmaceutical firm CSL Ltd said first-half profit fell as the Omicron COVID-19 outbreak stopped people giving blood plasma, the core of its treatments, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results